Genetic Variation in Toll-Like Receptors (TLRs) 2, 4, and 9 Influences HIV Disease Progression Toward Active TB and AIDS

References

• India HIV estimates 2021. National Aids Control Organization. Ministry of Health & Family Welfare, Government of India, National Aids Control Organization. Available from: https://naco.gov.in/. Accessed November 19, 2023.
   Google Scholar
• Kaushik G, Vashishtha R. Influence of genetic variability in toll-like receptors (TLR 2, TLR 4, and TLR 9) on human immunodeficiency virus-1 disease progression. Int J Mycobacteriol. 2023;12(1):10–16. doi:10.4103/ijmy.ijmy_190_22
   PubMed Web of Science ®Google Scholar
• Yadav RN, Verma AK, Kaushik G. Laboratory Cost Analysis of Conventional and Newer Molecular Tests for Diagnosis of Presumptive Multidrug-Resistant Tuberculosis Patients. J Glob Infect Dis. 2022;14(3):93–98. doi:10.4103/jgid.jgid_309_21
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven AJ. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS. 2007;21(10):1375–1377. doi:10.1097/QAD.0b013e32814e6b2d
   PubMed Web of Science ®Google Scholar
• Ferwerda B, McCall MB, Verheijen K, et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med. 2008;14(5–6):346–352. doi:10.2119/2007-00135.Ferwerda
   PubMed Web of Science ®Google Scholar
• Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140(6):1729–1737. doi:10.1053/j.gastro.2011.02.012
   PubMed Web of Science ®Google Scholar
• Verma C, Swami B, Upadhyay V, et al. Tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome in HIV: immunological review of manifestation and immunopathogenesis. Int J HIV-Related Problems. 2020;19(2):67–73. doi:10.5114/hivar.2020.96486
   Google Scholar
• Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics. 2015;8:37. doi:10.1186/s12920-015-0115-z
   PubMed Web of Science ®Google Scholar
• Altfeld M, Kalife ET, Qi Y, et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med. 2006;3(10):e403. doi:10.1371/journal.pmed.0030403
   PubMed Web of Science ®Google Scholar
• Bochud PY, Hersberger M, Taffé P, et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS. 2007;21(4):441–446. doi:10.1097/QAD.0b013e328012b8ac
   PubMed Web of Science ®Google Scholar
• Báfica A, Scanga CA, Schito M, Chaussabel D, Sher A. Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J Immunol. 2004;172(12):7229–7234. doi:10.4049/jimmunol.172.12.7229
   PubMed Web of Science ®Google Scholar
• Heggelund L, Damås JK, Yndestad A, et al. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences. Clin Exp Immunol. 2004;138(1):116–121. doi:10.1111/j.1365-2249.2004.02595.x
   PubMed Web of Science ®Google Scholar
• Verma C, Sharma SK, Natarajan K, et al. Immunological alterations in tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in HIV-infected patients. Indian J Exp Biol. 2019;57(11):786–795.
   Web of Science ®Google Scholar
• Kaushik G, Vashishtha R, Tripathi H, Yadav RN. Genetic polymorphism of toll-like receptors in HIV-I infected patients with and without tuberculosis co-infection. Int J Mycobacteriol. 2022;11(1):95–102. doi:10.4103/ijmy.ijmy_4_22
   PubMedGoogle Scholar
• MacKichan ML. Toll bridge to immunity. Newsletter Int AIDS Vaccine Res. 2005;1–24.
   Google Scholar
• El-Zayat SR, Sibaii H, Mannaa FA. Toll-like receptors activation, signaling, and targeting: an overview. Bull Natl Res Cent. 2019;43(1):187. doi:10.1186/s42269-019-0227-2
   Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801. doi:10.1016/j.cell.2006.02.015
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3(2):196–200. doi:10.1038/ni758
   PubMed Web of Science ®Google Scholar
• Bowie AG, Haga IR. The role of Toll-like receptors in the host response to viruses. Mol Immunol. 2005;42(8):859–867. doi:10.1016/j.molimm.2004.11.007
   PubMed Web of Science ®Google Scholar
• Schröder NW, Diterich I, Zinke A, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol. 2005;175(4):2534–2540. doi:10.4049/jimmunol.175.4.2534
   PubMed Web of Science ®Google Scholar
• Schröder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis. 2005;5(3):156–164. doi:10.1016/S1473-3099(05)01308-3
   PubMed Web of Science ®Google Scholar
• Kaushik G, Vashishtha R. Messenger RNA expression of toll-like receptors (TLR2, TLR4, and TLR9) in HIV-1 infected patients with and without tuberculosis co-infection. Int J Mycobacteriol. 2022;11(3):293–298. doi:10.4103/ijmy.ijmy_108_22
   PubMed Web of Science ®Google Scholar
• Folwaczny M, Glas J, Török HP, Limbersky O, Folwaczny C. Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin Exp Immunol. 2004;135(2):330–335. doi:10.1111/j.1365-2249.2004.02383.x
   PubMed Web of Science ®Google Scholar
• Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques. 2001;31(1):22–24. doi:10.2144/01311bm01
   PubMed Web of Science ®Google Scholar
• Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, et al. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr. 2008;49(2):128–135. doi:10.1097/QAI.0b013e318184fb41
   PubMed Web of Science ®Google Scholar
• Papadopoulos AI, Ferwerda B, Antoniadou A, et al. Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection. Clin Infect Dis. 2010;51(2):242–247. doi:10.1086/653607
   PubMed Web of Science ®Google Scholar
• Pine SO, McElrath MJ, Bochud PY. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS. 2009;23(18):2387–2395. doi:10.1097/QAD.0b013e328330b489
   PubMed Web of Science ®Google Scholar
• O’Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36(6):565–574. doi:10.1038/ng1369
   PubMed Web of Science ®Google Scholar